2022 annual financial data
ALX Oncology Holdings 2022 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -127,436,000 USD and net income was -123,482,000 USD.
Operating cash flow was -89,223,000 USD.
Get free ALX Oncology Holdings email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -127,436,000 USD
- Net income
- -123,482,000 USD
- Operating cash flow
- -89,223,000 USD